The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Open accessAbstract
BACKGROUND: Accumulating evidence suggests an association between prenatal exposure to antiepileptic drugs (AEDs) and increased risk of both physical anomalies and neurodevelopmental impairment. Neurodevelopmental impairment is characterised by either a specific deficit or a constellation of deficits across cognitive, motor and social skills and can be transient or continuous into adulthood. It is of paramount importance that these potential risks are identified, minimised and communicated clearly to women with epilepsy. OBJECTIVES: To assess the effects of prenatal exposure to commonly prescribed AEDs on neurodevelopmental outcomes in the child and to assess the methodological quality of the evidence. SEARCH METHODS: We searched the Cochrane Epilepsy Group Specialized Register (May 2014), Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (2014, Issue 4), MEDLINE (via Ovid) (1946 to May 2014), EMBASE (May 2014), Pharmline (May 2014) and Reprotox (May 2014). No language restrictions were imposed. Conference abstracts from the last five years were reviewed along with reference lists from the included studies. SELECTION CRITERIA: Prospective cohort controlled studies, cohort studies set within pregnancy registers and randomised controlled trials were selected for inclusion. Participants were women with epilepsy taking AED treatment; the two control groups were women without epilepsy and women with epilepsy who were not taking AEDs during pregnancy. DATA COLLECTION AND ANALYSIS: Three authors (RB, JW and JG) independently selected studies for inclusion. Data extraction and risk of bias assessments were completed by five authors (RB, JW, AS, NA, AJM). The primary outcome was global cognitive functioning. Secondary outcomes included deficits in specific cognitive domains or prevalence of neurodevelopmental disorders. Due to substantial variation in study design and outcome reporting only limited data synthesis was possible. MAIN RESULTS: Twenty-two prospective cohort studies were included and six registry based studies. Study quality varied. More recent studies tended to be larger and to report individual AED outcomes from blinded assessments, which indicate improved methodological quality.The developmental quotient (DQ) was lower in children exposed to carbamazepine (CBZ) (n = 50) than in children born to women without epilepsy (n = 79); mean difference (MD) of -5.58 (95% confidence interval (CI) -10.83 to -0.34, P = 0.04). The DQ of children exposed to CBZ (n = 163) was also lower compared to children of women with untreated epilepsy (n = 58) (MD -7.22, 95% CI -12.76 to - 1.67, P = 0.01). Further analysis using a random-effects model indicated that these results were due to variability within the studies and that there was no significant association with CBZ. The intelligence quotient (IQ) of older children exposed to CBZ (n = 150) was not lower than that of children born to women without epilepsy (n = 552) (MD -0.03, 95% CI -3.08 to 3.01, P = 0.98). Similarly, children exposed to CBZ (n = 163) were not poorer in terms of IQ in comparison to the children of women with untreated epilepsy (n = 87) (MD 1.84, 95% CI -2.13 to 5.80, P = 0.36). The DQ in children exposed to sodium valproate (VPA) (n = 123) was lower than the DQ in children of women with untreated epilepsy (n = 58) (MD -8.72, 95% -14.31 to -3.14, P = 0.002). The IQ of children exposed to VPA (n = 76) was lower than for children born to women without epilepsy (n = 552) (MD -8.94, 95% CI -11.96 to -5.92, P < 0.00001). Children exposed to VPA (n = 89) also had lower IQ than children born to women with untreated epilepsy (n = 87) (MD -8.17, 95% CI -12.80 to -3.55, P = 0.0005).In terms of drug comparisons, in younger children there was no significant difference in the DQ of children exposed to CBZ (n = 210) versus VPA (n=160) (MD 4.16, 95% CI -0.21 to 8.54, P = 0.06). However, the IQ of children exposed to VPA (n = 112) was significantly lower than for those exposed to CBZ (n = 191) (MD 8.69, 95% CI 5.51 to 11.87, P < 0.00001). The IQ of children exposed to CBZ (n = 78) versus lamotrigine (LTG) (n = 84) was not significantly different (MD -1.62, 95% CI -5.44 to 2.21, P = 0.41). There was no significant difference in the DQ of children exposed to CBZ (n = 172) versus phenytoin (PHT) (n = 87) (MD 3.02, 95% CI -2.41 to 8.46, P = 0.28). The IQ abilities of children exposed to CBZ (n = 75) were not different from the abilities of children exposed to PHT (n = 45) (MD -3.30, 95% CI -7.91 to 1.30, P = 0.16). IQ was significantly lower for children exposed to VPA (n = 74) versus LTG (n = 84) (MD -10.80, 95% CI -14.42 to -7.17, P < 0.00001). DQ was higher in children exposed to PHT (n = 80) versus VPA (n = 108) (MD 7.04, 95% CI 0.44 to 13.65, P = 0.04). Similarly IQ was higher in children exposed to PHT (n = 45) versus VPA (n = 61) (MD 9.25, 95% CI 4.78 to 13.72, P < 0.0001). A dose effect for VPA was reported in six studies, with highe
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Common antiepileptic drugs in pregnancy in women with epilepsy
Adab, N., Smith, C. T., Vinten, J., Williamson, P. R., & Winterbottom, J. B. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004848 · Cited by 120
Self-citationRetractedGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Intelligence and educational achievement
Deary, I. J., Strand, S., Smith, P., & Fernandes, C. (2007) · Intelligence · doi:10.1016/j.intell.2006.02.001 · Cited by 1,723
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Kirkham, J. J., Dwan, K. M., Altman, D. G., Gamble, C., Dodd, S., Smyth, R., & Williamson, P. R. (2010) · BMJ · doi:10.1136/bmj.c365 · Cited by 1,133
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Murphy, D. P. (1953) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)34089-0 · Cited by 1,069
Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70323-x · Cited by 834
Self-citationCognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Comparative safety of antiepileptic drugs during pregnancy
Hernández-Díaz, S., Smith, C. R., Shen, A., Mittendorf, R., Hauser, W. A., Yerby, M., Holmes, L. B., For the North American AED Pregnancy Registry, North American AED (Antiepileptic Drug) Pregnancy Registry, Cragan, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f39 · Cited by 620
Epilepsy: Frequency Causes and Consequences
Hauser, W. A., & Hesdorffer, D. C. (1990) · Medical Entomology and Zoology · Cited by 587
The longer term outcome of children born to mothers with epilepsy
Adab, N. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029132 · Cited by 580
Self-citationA clinical study of 57 children with fetal anticonvulsant syndromes
Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., & Dean, J. C. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.7.489 · Cited by 562
Epilepsy: Frequency, causes and consequences
Messenheimer, J. A. (1991) · Journal of Epilepsy · doi:10.1016/0896-6974(91)90095-z · Cited by 562
Characteristics of fetal anticonvulsant syndrome associated autistic disorder
Rasalam, A., Hailey, H., Williams, J., Moore, S., Turnpenny, P., Lloyd, D., & Dean, J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205001076 · Cited by 456
Pattern of Malformations in the Children of Women Treated with Carbamazepine during Pregnancy
Jones, K. L., Lacro, R. V., Johnson, K. A., & Adams, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906223202505 · Cited by 447
Hanson, J. W., Myrianthopoulos, N. C., Harvey, M. A. S., & Smith, D. W. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80414-3 · Cited by 434
Meador, K., Reynolds, M. W., Crean, S., Fahrbach, K., & Probst, C. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.04.022 · Cited by 400
Neuropsychological Evaluation of the Child
Baron, I. S. (2003) · Cited by 399
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs
Bromley, R. L., Mawer, G. E., Briggs, M., Cheyne, C., Clayton-Smith, J., Garcia-Finana, M., Kneen, R., Lucas, S. B., Shallcross, R., Baker, G. A., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304270 · Cited by 367
Self-citationArndt, T. L., Stodgell, C. J., & Rodier, P. M. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.11.001 · Cited by 360
Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling Pairs
Christianson, A. L., Chester, N., & Kromberg, J. G. R. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11858.x · Cited by 336
Antiepileptic Drugs and Apoptosis in the Developing Brain
BITTIGAU, P., SIFRINGER, M., & IKONOMIDOU, C. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07517.x · Cited by 302
Verification of the fetal valproate syndrome phenotype
Ardinger, H. H., Atkin, J. F., Blackston, R. D., Elsas, L. J., Clarren, S. K., Livingstone, S., Flannery, D. B., Pellock, J. M., Harrod, M. J., Lammer, E. J., et al. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290123 · Cited by 302
Normal intelligence in children with prenatal exposure to carbamazepine
Gaily, E., Kantola-Sorsa, E., Hiilesmaa, V., Isoaho, M., Matila, R., Kotila, M., Nylund, T., Bardy, A., Kaaja, E., & Granström, M. L. (2004) · Neurology · doi:10.1212/wnl.62.1.28 · Cited by 295
Additional educational needs in children born to mothers with epilepsy
Adab, N. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.15 · Cited by 282
Self-citationAUTISM SPECTRUM DISORDERS FOLLOWING IN UTERO EXPOSURE TO ANTIEPILEPTIC DRUGS
Bromley, R. L., Mawer, G., Clayton-Smith, J., & Baker, G. A. (2008) · Neurology · doi:10.1212/01.wnl.0000339399.64213.1a · Cited by 269
Self-citationLong term health and neurodevelopment in children exposed to antiepileptic drugs before birth
Dean, J. C. S., Hailey, H., Moore, S. J., Lloyd, D. J., Turnpenny, P. D., & Little, J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.251 · Cited by 252
In utero exposure to phenobarbital and intelligence deficits in adult men
Reinisch, J. M. (1995) · JAMA · doi:10.1001/jama.274.19.1518 · Cited by 238
In Utero Exposure to Phenobarbital and Intelligence Deficits in Adult Men
Reinisch, J. M., Sanders, S. A., Mortensen, E. L., & Rubin, D. B. (1995) · JAMA · doi:10.1001/jama.1995.03530190032031 · Cited by 235
Breastfeeding in Children of Women Taking Antiepileptic Drugs: Cognitive Outcomes at Age 6 Years
Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.118 · Cited by 226
Self-citationNeurodevelopment of Children Exposed In Utero to Phenytoin and Carbamazepine Monotherapy
Scolnik, D. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510340057034 · Cited by 216
Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine
Cummings, C., Stewart, M., Stevenson, M., Morrow, J., & Nelson, J. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2009.176990 · Cited by 205
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy
(1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70035-4 · Cited by 204
Miyazaki, K., Narita, N., & Narita, M. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.05.004 · Cited by 197
Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years
Cohen, M. J., Meador, K. J., Browning, N., May, R., Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.08.001 · Cited by 180
Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.
Ornoy, A., & Cohen, E. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.75.6.517 · Cited by 179
A male with fetal valproate syndrome and autism
Williams, P. G., & Hersh, J. H. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07500.x · Cited by 178
Exposure to antiepileptic drugs in utero and child development: A prospective population‐based study
Veiby, G., Daltveit, A. K., Schjølberg, S., Stoltenberg, C., Øyen, A., Vollset, S. E., Engelsen, B. A., & Gilhus, N. E. (2013) · Epilepsia · doi:10.1111/epi.12226 · Cited by 177
Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers
Mawhinney, E., Craig, J., Morrow, J., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0874 · Cited by 165
Clayton-Smith, J., & Donnai, D. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.9.724 · Cited by 164
Child development following in utero exposure: Levetiracetam vs sodium valproate
Shallcross, R., Bromley, R. L., Irwin, B., Bonnett, L. J., Morrow, J., & Baker, G. A. (2011) · Neurology · doi:10.1212/wnl.0b013e3182088297 · Cited by 161
Self-citationEarly cognitive development in children born to women with epilepsy: A prospective report
Bromley, R. L., Mawer, G., Love, J., Kelly, J., Purdy, L., McEwan, L., Briggs, M., Smith, J. C., Sin, X., & Baker, G. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02668.x · Cited by 161
Self-citationLindhout, D., Meinardi, H., Meijer, J. W. A., & Nau, H. (1992) · PubMed · Cited by 160
Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age
Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., et al. (2011) · Brain · doi:10.1093/brain/awq352 · Cited by 159
Epilepsy, pregnancy, and the child
Janz, D. (1982) · Raven Press eBooks · Cited by 143
Intelligence of children of epileptic mothers
Gally, E., Kantola‐Sorsa, E., & Granström, M. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80377-9 · Cited by 142
Effects of breastfeeding in children of women taking antiepileptic drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton‐Smith, J., Combs‐Cantrell, D. T., Cohen, M. J., Kalayjian, L. A., Kanner, A. M., Liporace, J. D., Pennell, P. B., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4a9 · Cited by 141
Eriksson, K. J., Viinikainen, K., Mönkkönen, A., Äikiä, M., Nieminen, P., Heinonen, S. T., & Kälviäinen, R. K. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.06.001 · Cited by 139
Veiby, G., Engelsen, B. A., & Gilhus, N. E. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4290 · Cited by 138
Neuropsychological evaluation of the child
Speedie, L. J. (2004) · Annals of Neurology · doi:10.1002/ana.20046 · Cited by 133
Koch, S., Titze, K., Zimmermann, R. B., Schröder, M., Lehmkuhl, U., & Rauh, H. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00852.x · Cited by 132
Understanding the Neuropsychological Consequences of Deployment Stress: A Public Health Framework
Vasterling, J. J., & Proctor, S. P. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001116 · Cited by 126
Language skills of school-aged children prenatally exposed to antiepileptic drugs
Nadebaum, C., Anderson, V., Vajda, F. J. E., Reutens, D. C., Barton, S., & WOOD, A. G. (2011) · Neurology · doi:10.1212/wnl.0b013e31820d62c7 · Cited by 120
Vanoverloop, D., Schnell, R. R., Harvey, E. A., & Holmes, L. B. (1992) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(92)90039-d · Cited by 118
SPECIFIC COGNITIVE DYSFUNCTION IN CHILDREN WITH EPILEPTIC MOTHERS
Gaily, E. K., Kantola‐Sorsa, E., & Granström, M. (1990) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1990.tb16959.x · Cited by 115
Antiepileptic drug use in women of childbearing age
Meador, K. J., Penovich, P. E., Baker, G. A., Pennell, P. B., Bromfield, E. B., Pack, A. M., Liporace, J. D., Sam, M. C., Kalayjian, L. A., Thurman, D. J., et al. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.04.026 · Cited by 111
Motor and mental development of infants exposed to antiepileptic drugs in utero
Thomas, S. V., Ajaykumar, B., Sindhu, K., Nair, M. K. C., George, B., & Sarma, P. S. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.01.010 · Cited by 109
Banach, R., Boskovic, R., Einarson, T., & Koren, G. (2010) · Drug Safety · doi:10.2165/11317640-000000000-00000 · Cited by 105
Nadebaum, C., Anderson, V. A., Vajda, F. J. E., Reutens, D. C., Barton, S., & WOOD, A. G. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001359 · Cited by 105
Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome
Koch, S., Jäger‐Roman, E., Lösche, G., Nau, H., Rating, D., & Helge, H. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14137.x · Cited by 103
Dessens, A. B., Cohen‐Kettenis, P. T., Mellenbergh, G. J., Koppe, J. G., van de Poll, N. E., & Boer, K. (2000) · Acta Paediatrica · doi:10.1080/080352500750027808 · Cited by 101
Fetal valproate syndrome: is there a recognisable phenotype?
Winter, R. M., Donnai, D., Burn, J., & Tucker, S. M. (1987) · Journal of Medical Genetics · doi:10.1136/jmg.24.11.692 · Cited by 95
In utero exposure to levetiracetam vs valproate
Shallcross, R., Bromley, R., Cheyne, C. P., García‐Fiñana, M., Irwin, B., Morrow, J. I., & Baker, G. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000030 · Cited by 93
Self-citationPsychomotor development in preschool children exposed to antiepileptic drugs in utero
Wide, K., Henning, E., Tomson, T., & Winbladh, B. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb01663.x · Cited by 92
Cohen, M. J., Meador, K. J., Browning, N., Baker, G. A., Clayton‐Smith, J., Kalayjian, L. A., Kanner, A. M., Liporace, J. D., Pennell, P. B., Privitera, M., et al. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.06.014 · Cited by 87
Mortensen, J. T., Olsen, J. H., Larsen, H., Bendsen, J., Obel, C., & Sørensen, H. T. (2003) · European Journal of Epidemiology · doi:10.1023/a:1025306304635 · Cited by 85
Teratogenicity of anticonvulsant drugs. II: A prospective study
Kelly, T. E., Edwards, P., Rein, M., Miller, J. Q., & Dreifuss, F. E. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320190303 · Cited by 85
Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study.
Tanganelli, P., & Regesta, G. (1992) · PubMed · Cited by 85
Wide, K., Winbladh, B., Tomson, T., Sars‐Zimmer, K., & Berggren, E. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200000177 · Cited by 82
Intelligence and physical features of children of women with epilepsy
Holmes, L. B., Rosenberger, P. B., Harvey, E. A., Khoshbin, S., & RYAN, L. M. (2000) · Teratology · doi:10.1002/(sici)1096-9926(200003)61:3<196::aid-tera7>3.0.co;2-t · Cited by 78
Pregnancy, Teratogenesis, and Epilepsy
Yerby, M. S. (1994) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30075-6 · Cited by 75
Intellectual and language functions in children of mothers with epilepsy
Thomas, S. V., Sukumaran, S., Lukose, N., George, A., & Sarma, P. S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01376.x · Cited by 75
Epilepsy in pregnancy: developmental outcome of offspring at 12 months.
Leavitt, A., Yerby, M. S., Robinson, N., Sells, C. J., & Erickson, D. (1992) · PubMed · Cited by 74
Lösche, G., Steinhausen, H. ‐., Koch, S., & Helge, H. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13181.x · Cited by 66
McVearry, K. M., Gaillard, W. D., VanMeter, J. W., & Meador, K. J. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.09.024 · Cited by 66
Titze, K., Koch, S., Helge, H., et al. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2007.02020.x · Cited by 65
Changing trends in antiepileptic drug prescribing in girls of child-bearing potential
Ackers, R., Besag, F., Wade, A. M., Murray, M. L., & Wong, I. C. K. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.144386 · Cited by 63
Viinikainen, K., Eriksson, K. J., Mönkkönen, A., Äikiä, M., Nieminen, P., Heinonen, S. T., & Kälviäinen, R. K. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.08.007 · Cited by 60
Psychobiology and Early Development
(1987) · Advances in psychology · doi:10.1016/s0166-4115(08)x6014-5 · Cited by 58
Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero
Bromley, R., Baker, G. A., & Meador, K. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283292401 · Cited by 57
Self-citationGladstone, D. J., Bologa, M., Maguire, C., et al. (1992) · Reproductive Toxicology · doi:10.1016/0890-6238(92)90181-r · Cited by 57
Rihtman, T., Parush, S., & Ornoy, A. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.06.001 · Cited by 55
Nicolai, J., Vles, J. S. H., & Aldenkamp, A. P. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.03.004 · Cited by 52
Holmes, L. B., Coull, B. A., Dorfman, J. D., & Rosenberger, P. B. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.08.048 · Cited by 48
Fetal phenytoin exposure, hypoplastic nails, and jitteriness.
D'Souza, S. W., Robertson, I. G., Donnai, D., & Mawer, G. E. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.3.320 · Cited by 45
Neuropsychological outcomes in children of mothers with epilepsy
Kantola‐Sorsa, E., Gaily, E. K., ISOAHO, M., & Korkman, M. (2007) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617707070804 · Cited by 44
Renowden, S. A., & Squier, M. V. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11857.x · Cited by 42
Forsberg, L., Wide, K., & Källén, B. A. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02778.x · Cited by 36
Effects of maternal epilepsy on children's neurodevelopment
ROVET, J. F., Cole, S., Nulman, I., Scolnik, D., Altmann, D., & Koren, G. (1995) · Child Neuropsychology · doi:10.1080/09297049508402246 · Cited by 27
Parisi, P., Francia, A., Vanacore, N., Fiore, S., Giallonardo, A. T., & Manfredi, M. (2003) · Early Human Development · doi:10.1016/s0378-3782(03)00083-5 · Cited by 25
Checking the health of school entrants.
Whitmore, K., & BAX, M. C. O. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.3.320 · Cited by 23
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects
Friedman, J. M. (2012) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23043 · Cited by 16
Physical growth and psychomotor development of infants exposed to antiepileptic drugsin utero
Dhanaraj, M., Rangaraj, R., Vengatesan, A., et al. (2006) · Neurology India · doi:10.4103/0028-3886.24701 · Cited by 15
Antiepileptic drugs and teratogenicity in Nigerians
Lekwuwa, G., Adewole, I. F., & Thompson, M. O. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90507-3 · Cited by 4
Perniola, T., Buttiglione, M., & Margari, L. (1992) · PubMed · Cited by 4
Shallcross, R. (n.d.) · OpenGrey (Institut de l'Information Scientifique et Technique) · doi:10.17638/03062712 · Cited by 1
Devenir cognitif des enfants nés de mères épileptiques
Mancini, J., Milh, M., & Chabrol, B. (2009) · Epilepsies · doi:10.1684/epi.2009.0266 · Cited by 1
Cited by
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
Weston, J., Bromley, R., Jackson, C. F., Adab, N., Clayton-Smith, J., Greenhalgh, J., Hounsome, J., McKay, A. J., Tudur Smith, C., & Marson, A. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010224.pub2 · Cited by 347
Self-citationMcAllister-Williams, R. H., Baldwin, D. S., Cantwell, R., Easter, A., Gilvarry, E., Glover, V., Green, L., Gregoire, A., Howard, L. M., Jones, I., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699361 · Cited by 271
Valproate in the treatment of epilepsy in girls and women of childbearing potential
Tomson, T., Marson, A., Boon, P., Canevini, M. P., Covanis, A., Gaily, E., Kälviäinen, R., & Trinka, E. (2015) · Epilepsia · doi:10.1111/epi.13021 · Cited by 267
Self-citationBjørk, M.-H., Zoega, H., Leinonen, M. K., Cohen, J. M., Dreier, J. W., Furu, K., Gilhus, N. E., Gissler, M., Hálfdánarson, Ó., Igland, J., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.1269 · Cited by 267
Tomson, T., Battino, D., & Perucca, E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00314-2 · Cited by 266
Metadata
- Authors
- Bromley, R., Weston, J., Adab, N., Greenhalgh, J., Sanniti, A., McKay, A. J., Tudur Smith, C., & Marson, A. G.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-10-30
- Volume
- 2020
- Issue
- 6
- Pages
- CD010236-CD010236
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1917794385
- Cited by
- 277
- References
- 101
- FWCI
- 18.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.